Even though these two cytokines share the strongest sequence homology and both modulate pro-inflammatory responses, IL-17A, but not IL-17F, has been demonstrated to play a role in hypertension-associated end-organ damages for cardiac, vascular, and renal injuries [12,13,14]. This evidence concerns the gene IL17A and hypertensive disorder.